共 50 条
- [31] Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (01): : 40 - 46
- [33] Radiotherapy of exudative age-related macular degeneration; a clinical and pathologic study Graefe's Archive for Clinical and Experimental Ophthalmology, 2001, 239 : 539 - 543
- [34] INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (09): : 1815 - 1827
- [40] Comparative Review of Ranibizumab versus Bevacizumab in the Treatment of Neovascular Age-related Macular Degeneration CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 491 - 497